Cleared Traditional

K925295 - EXACTA-SPEZIAL

K925295 is an FDA 510(k) clearance for EXACTA-SPEZIAL, manufactured by Rudolf Riester GmbH & Co. KG. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 520-day FDA review.

K925295 · Rudolf Riester GmbH & Co. KG · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1994
Decision
520d
Days
Class 2
Risk

K925295 is an FDA 510(k) clearance for the EXACTA-SPEZIAL. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Rudolf Riester GmbH & Co. KG (D-72417 Jungingen, DE). The FDA issued a Cleared decision on March 25, 1994 after a review of 520 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Rudolf Riester GmbH & Co. KG devices

FDA 510(k) Submission Details - K925295

510(k) Number K925295 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 21, 1992
Decision Date March 25, 1994
Days to Decision 520 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
395d slower than avg
Panel avg: 125d · This submission: 520d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 569
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K925295.
A & D UB-302 WRIST DIGITAL BLOOD PRESSURE MONITOR
K960319 · A&D Engineering, Inc. · Jul 1996
NON-INVASIVE BLOOD PRESSURE (NIBP) MONITOR (MODEL 90553)
K941167 · Spacelabs Medical, Inc. · Nov 1994
DTX AND DTX PLUS DISPOSABLE PRESSURE TRANSDUCERS AND ACCESSORIES
K935782 · Ohmeda Medical · Aug 1994
PRECISA
K925294 · Rudolf Riester GmbH & Co. KG · Feb 1994
OSCILLOMATE BLOOD PRESSURE MONITOR-MODEL 9300
K925402 · Cas Medical Systems, Inc. · Sep 1993
CRITIKON VITAL SIGNS MODULE
K915697 · Critikon Company, LLC · Jul 1993